Aspen Grove Capital’s Eli Lilly LLY Stock Holding History

Aspen Grove Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.91M	Hold	4,253	–	–	0.76%	26
2025 Q4	$4.57M	Hold	4,253	–	–	0.79%	24
2025 Q3	$3.25M	Sell	4,253 -150	-3%	-$112K	0.55%	30
2025 Q2	$3.43M	Buy	4,403 +403	+10%	+$313K	0.58%	29
2025 Q1	$3.3M	Buy	4,000 +21	+0.5%	+$17.5K	0.64%	26
2024 Q4	$3.07M	Buy	3,979 +4	+0.1%	+$3.31K	0.65%	29
2024 Q3	$3.52M	Sell	3,975 -66	-2%	-$59.3K	0.78%	22
2024 Q2	$3.66M	Buy	4,041 +64	+2%	+$51.2K	0.86%	21
2024 Q1	$3.09M	Buy	3,977 +76	+2%	+$54.1K	0.88%	22
2023 Q4	$2.26M	Buy	3,901 +69	+2%	+$40.3K	0.69%	31
2023 Q3	$2.06M	Buy	3,832 +2,267	+145%	+$1.17M	0.76%	29
2023 Q2	$734K	Buy	1,565 +520	+50%	+$218K	0.24%	83
2023 Q1	$359K	Buy	1,045 +152	+17%	+$51.3K	0.16%	104
2022 Q4	$327K	Buy	+893	New	+$317K	0.15%	105

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aspen Grove Capital's LLY Position: Q1 2026 in Review

Aspen Grove Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 4,253 shares worth $3.91M. The position accounts for 0.76% of the portfolio, ranked #26.

Aspen Grove Capital first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.57M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Aspen Grove Capital held 4,253 shares of Eli Lilly worth $3.91M as of Q1 2026.
Aspen Grove Capital left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.76% of Aspen Grove Capital's portfolio in Q1 2026, its #26 holding.
Aspen Grove Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Aspen Grove Capital's Eli Lilly position peaked at $4.57M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aspen Grove Capital's 13F filing for Q1 2026, filed 14 May 2026.